Evoke Pharma, Inc. (EVOK)
收市後：
| 前收市價 | 0.4435 |
| 開市 | 0.4345 |
| 買盤 | 0.3105 x 200 |
| 賣出價 | 0.5648 x 200 |
| 今日波幅 | 0.4310 - 0.4500 |
| 52 週波幅 | 0.4160 - 2.4000 |
| 成交量 | |
| 平均成交量 | 40,874 |
| 市值 | 3.794M |
| Beta 值 (5 年，每月) | 0.30 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.3300 |
| 業績公佈日 | 2024年5月13日 - 2024年5月17日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
Insider MonkeyEvoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
InvestorPlace7 Under-the-Radar Growth Stocks Ready to Make a Splash
If I’m looking to outperform the market over time, I’m usually going to buy growth stocks. While value stocks have a place in any portfolio, growth stocks are the ones that keep the returns rolling in. Usually, companies represented by growth stocks are innovative and quickly adapt to changing times. By being involved in some of the most creative industries, such as biotechnology, technology and green energy, growth stocks help you capitalize on emerging trends and technologies. I also like grow
